These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6011754)

  • 21. [Appearance of drug-resistance to alkylating agents in Jensen's sarcoma and its clones].
    ZHDANOV GL; SHARLIKOVA LF
    Vopr Onkol; 1961; 7(12)():26-31. PubMed ID: 14010206
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combined drug and radiation therapy of IMR-1 sarcoma with regard to its mitotic activity].
    Kharlampovich SI
    Vopr Onkol; 1970; 16(1):75-82. PubMed ID: 5434579
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of serotonin and sarcolysin on blood nucleic acid levels in sarcoma 45 in rats].
    Reznichenko GI
    Vopr Onkol; 1966; 12(6):62-4. PubMed ID: 6000107
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the structure of DNA induced by sarcolysine in vivo and in vitro].
    Babaian IuC; Garibian DV; Danielian IS; Aslanian VM; Garibdzhanian BT
    Vopr Med Khim; 1984; 30(5):92-5. PubMed ID: 6528526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The protective effect of AET, cystamine and cystaphos when using lethal doses of antineoplastic drugs].
    Larionov LF; Spasskaia IG
    Vopr Onkol; 1968; 14(12):33-9. PubMed ID: 5714181
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacologic and clinical studies on n-formyl-sarcolysine.
    Chinas Med; 1967 Aug; 8():606-23. PubMed ID: 5588881
    [No Abstract]   [Full Text] [Related]  

  • 27. [The anti-tumor activity of 5-di(2-chlorethyl)amino DL-tryptophan].
    Trusheĭkina VI; Larionov LF
    Vopr Onkol; 1969; 15(10):96-100. PubMed ID: 5372756
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of treating a bone sarcoma with sarcolysine].
    Terekhov PF
    Veterinariia; 1971 Aug; 9():86. PubMed ID: 5140688
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electron microscopic characteristics of brain mitochondria and oxidative phosphorylation in convulsive states of different aetiology].
    Petrov VS
    Biofizika; 1966; 11(4):605-10. PubMed ID: 6000619
    [No Abstract]   [Full Text] [Related]  

  • 30. [Regression of rat sarcoma 45 at single administration of sarcolysine, asalin and asalei].
    Syrkin AB; Solenov VN
    Farmakol Toksikol; 1969; 32(6):723-6. PubMed ID: 5381606
    [No Abstract]   [Full Text] [Related]  

  • 31. Janus green B and the biologic "oxygen effect".
    Braun S; Erdelyi M; Udvardy A
    Cancer Res; 1967 Apr; 27(4):660-7. PubMed ID: 6025729
    [No Abstract]   [Full Text] [Related]  

  • 32. [CHANGES IN THE SUBMICROSCOPIC STRUCTURE OF CELLS OF SARCOMA 45 DURING THE REGRESSION PROCESS UNDER THE EFFECT OF SARCOLYSINE].
    PROSHCHENKO VG
    Tsitologiia; 1965; 7(1):32-8. PubMed ID: 14340276
    [No Abstract]   [Full Text] [Related]  

  • 33. [SENSITIVITY OF TUMOR CELLS TO SARCOLYSINE IN VITRO].
    SURIKOV IM
    Tsitologiia; 1965; 7(1):83-7. PubMed ID: 14340283
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of artificial hyperglycaemia on selected clinico-chemical parameters of Wistar-rats with Jensen's sarcoma (author's transl)].
    Begand M; Begand R; Hambsch K; Ludewig R; Rotzsch W
    Arch Geschwulstforsch; 1980; 50(7):628-34. PubMed ID: 7235862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [VASCULAR BED OF SARCOMA-45 INOCULATED INTRAMUSCULARLY DURING THE COURSE OF GROWTH AND TREATMENT WITH SARCOLYSINE].
    KRYLOVA NV; PRESNOV MA
    Arkh Anat Gistol Embriol; 1964 Sep; 47():73-8. PubMed ID: 14252081
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quantiative determination of some metabolites in Jensen's sarcoma].
    HOHORST HJ; ARESE P
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1792-4. PubMed ID: 13961236
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the conditions of equilibrium of some cytoplasmic reaction in Jensen's sarcoma].
    HOHORST HJ; ARESE P
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1795-8. PubMed ID: 13961235
    [No Abstract]   [Full Text] [Related]  

  • 38. [Formation of antibodies to sarcolysine and their influence on its antitumorous activity].
    Nikolaev AI; Akhmadieva AKh; Makarov GF
    Biull Eksp Biol Med; 1965 Jul; 60(7):95-8. PubMed ID: 5880716
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.
    Brunstein F; Hoving S; aan de Wiel-Ambagtsheer G; de Bruijn EA; Guetens G; Eggermont AM; ten Hagen TL
    Cancer Immunol Immunother; 2007 Apr; 56(4):573-80. PubMed ID: 16896966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine).
    LARIONOV LF; SHKODINSKAJA EN; TROOSHEIKINA VI; KHOKHLOV AS; VASINA OS; NOVIKOVA MA
    Lancet; 1955 Jul; 269(6882):169-71. PubMed ID: 13243678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.